| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年三季报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 血液灌流器(元) | 79,349,070.33 | 152,729,289.71 | 70,551,690.17 | 132,812,643.80 | 96,953,680.90 |
| 血液净化配套产品(元) | 7,722,048.78 | 16,033,704.18 | 8,226,291.77 | 7,095,675.86 | 4,354,768.79 |
| 血液透析器(元) | 209,715,150.17 | 421,385,056.05 | 214,853,038.64 | 341,568,875.78 | 239,818,329.70 |
| 血液透析设备(元) | 11,664,670.34 | 21,643,556.93 | 3,813,447.10 | 779,825.13 | - |
| 营业成本(元) | |||||
| 血液灌流器(元) | 22,591,323.79 | 45,027,871.06 | 21,034,535.16 | 40,172,860.94 | - |
| 血液净化配套产品(元) | 7,960,649.30 | 15,193,805.04 | 7,435,820.96 | 6,514,548.25 | - |
| 血液透析器(元) | 114,259,489.20 | 239,141,873.45 | 121,156,033.98 | 188,241,914.10 | - |
| 血液透析设备(元) | 8,721,348.28 | 19,732,086.87 | 4,458,674.05 | 1,209,638.30 | - |
| 毛利(元) | |||||
| 血液灌流器(元) | 56,757,746.54 | 107,701,418.65 | 49,517,155.01 | 92,639,782.86 | - |
| 血液净化配套产品(元) | -238,600.52 | 839,899.14 | 790,470.81 | 581,127.61 | - |
| 血液透析器(元) | 95,455,660.97 | 182,243,182.60 | 93,697,004.66 | 153,326,961.68 | - |
| 血液透析设备(元) | 2,943,322.06 | 1,911,470.06 | -645,226.95 | -429,813.17 | - |
| 毛利率(%) | |||||
| 血液灌流器(%) | 71.53 | 70.52 | 70.19 | 69.75 | - |
| 血液净化配套产品(%) | -3.09 | 5.24 | 9.61 | 8.19 | - |
| 血液透析器(%) | 45.52 | 43.25 | 43.61 | 44.89 | - |
| 血液透析设备(%) | 25.23 | 8.83 | -16.92 | -55.12 | - |
| 收入构成(%) | |||||
| 血液灌流器(%) | 25.73 | 24.96 | 23.72 | 27.54 | 28.42 |
| 血液净化配套产品(%) | 2.50 | 2.62 | 2.77 | 1.47 | 1.28 |
| 血液透析器(%) | 67.99 | 68.88 | 72.23 | 70.83 | 70.30 |
| 血液透析设备(%) | 3.78 | 3.54 | 1.28 | 0.16 | - |
| 毛利构成(%) | |||||
| 血液灌流器(%) | 36.64 | 36.80 | 34.54 | 37.64 | - |
| 血液净化配套产品(%) | -0.15 | 0.29 | 0.55 | 0.24 | - |
| 血液透析器(%) | 61.62 | 62.26 | 65.36 | 62.30 | - |
| 血液透析设备(%) | 1.90 | 0.65 | -0.45 | -0.17 | - |